𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients

✍ Scribed by SPINOWITZ, BRUCE S; SCHWENK, MICHAEL H; JACOBS, PAULA M; BOLTON, W KLINE; KAPLAN, MARK R; CHARYTAN, CHAIM; GALLER, MARILYN

Book ID
109067391
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
98 KB
Volume
68
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FDA report: Ferumoxytol for intravenous
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Ferahemeβ„’ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise